|
1
|
Cubillas R and Rockey DC: Portal
hypertensive gastropathy: A review. Liver Int. 30:1094–1102.
2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
McCormack TT, Sims J, Eyre-Brook I,
Kennedy H, Goepel J, Johnson AG and Triger DR: Gastric lesions in
portal hypertension: Inflammatory gastritis or congestive
gastropathy? Gut. 26:1226–1232. 1985.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Guixé-Muntet S, Quesada-Vázquez S and
Gracia-Sancho J: Pathophysiology and therapeutic options for
cirrhotic portal hypertension. Lancet Gastroenterol Hepatol.
9:646–663. 2024.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Urrunaga NH and Rockey DC: Portal
hypertensive gastropathy and colopathy. Clin Liver Dis. 18:389–406.
2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tan SW: Molecular mechanism of portal
hypertensive gastropathy: An update. Clin Res Hepatol
Gastroenterol. 48(102423)2024.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Luo Z, Tian M, Yang G, Tan QR, Chen YB, Li
G, Zhang QW, Li YK, Wan P and Wu JG: Hypoxia signaling in human
health and diseases: Implications and prospects for therapeutics.
Signal Transduct Target Ther. 7(218)2022.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yuan XY, Ruan W, Bobrow B, Carmeliet P and
Eltzschig HK: Targeting hypoxia-inducible factors: Therapeutic
opportunities and challenges. Nat Rev Drug Discov. 23:175–200.
2024.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lee P, Chandel NS and Simon MC: Cellular
adaptation to hypoxia through hypoxia inducible factors and beyond.
Nat Rev Mol Cell Biol. 21:268–283. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Brooks GA: Lactate as a fulcrum of
metabolism. Redox Biol. 35(101454)2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sies H: Oxidative stress: A concept in
redox biology and medicine. Redox Biol. 4:180–183. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kierans SJ and Taylor CT: Glycolysis: A
multifaceted metabolic pathway and signaling hub. J Biol Chem.
300(107906)2024.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xiao YL, Zhang YW, Xie KD, Huang XL, Liu
XZ, Luo JJ and Tan SW: Mitochondrial dysfunction by FADDosome
promotes gastric mucosal injury in portal hypertensive gastropathy.
Int J Biol Sci. 20:2658–2685. 2024.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Tan S, Chen X, Xu M, Huang X, Liu H, Jiang
J, Lu Y, Peng X and Wu B: PGE2/EP4 receptor attenuated mucosal
injury via β-arrestin1/Src/EGFR-mediated proliferation in portal
hypertensive gastropathy. Br J Pharmacol. 174:848–866.
2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Xiao YL, Liu XZ, Xie KD, Luo JJ, Zhang YW,
Huang XL, Luo JN and Tan SW: Mitochondrial dysfunction induced by
HIF-1α under hypoxia contributes to the development of gastric
mucosal lesions. Clin Transl Med. 14(e1653)2024.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Tan S, Li L, Chen T, Chen X, Tao L, Lin X,
Tao J, Huang X, Jiang J, Liu H and Wu B: β-Arrestin-1 protects
against endoplasmic reticulum stress/p53-upregulated modulator of
apoptosis-mediated apoptosis via repressing p-p65/inducible nitric
oxide synthase in portal hypertensive gastropathy. Free Radic Biol
Med. 87:69–83. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gana JC, Cifuentes LI, Gattini D,
Villarroel Del Pino LA, Peña A and Torres-Robles R: Band ligation
versus beta-blockers for primary prophylaxis of oesophageal
variceal bleeding in children with chronic liver disease or portal
vein thrombosis. Cochrane Database Syst Rev.
9(CD010546)2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Noto JM, Piazuelo MB, Romero-Gallo J,
Delgado AG, Suarez G, Akritidou K, Girod Hoffman M, Roa JC, Taylor
CT and Peek RM Jr: Targeting hypoxia-inducible factor-1 alpha
suppresses Helicobacter pylori-induced gastric injury via
attenuation of both cag-mediated microbial virulence and
proinflammatory host responses. Gut Microbes.
15(2263936)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lin ZH, Song JL, Gao YK, Huang SH, Dou RZ,
Zhong PY, Huang GQ, Han L, Zheng JS, Zhang XY, et al:
Hypoxia-induced HIF-1α/lncRNA-PMAN inhibits ferroptosis by
promoting the cytoplasmic translocation of ELAVL1 in peritoneal
dissemination from gastric cancer. Redox Biol.
52(102312)2022.PubMed/NCBI View Article : Google Scholar
|
|
19
|
He C, Wang LB, Zhang JT and Xu H:
Hypoxia-inducible microRNA-224 promotes the cell growth, migration
and invasion by directly targeting RASSF8 in gastric cancer. Mol
Cancer. 16(35)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhang YF, Lu HW, Ji H and Li YM: p53
upregulated by HIF-1α promotes gastric mucosal epithelial cells
apoptosis in portal hypertensive gastropathy. Dig Liver Dis.
55:81–92. 2023.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Winter JM, Yadav T and Rutter J: Stressed
to death: Mitochondrial stress responses connect respiration and
apoptosis in cancer. Mol Cell. 82:3321–3332. 2022.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fuhrmann DC and Brüne B: Mitochondrial
composition and function under the control of hypoxia. Redox Biol.
12:208–215. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhang BY, Pan CY, Feng C, Yan CQ, Yu YJ,
Chen ZL, Guo CJ and Wang XX: Role of mitochondrial reactive oxygen
species in homeostasis regulation. Redox Rep. 27:45–52.
2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang SG, Bae JW, Park HJ and Koo DB:
Mito-TEMPO protects preimplantation porcine embryos against
mitochondrial fission-driven apoptosis through DRP1/PINK1-mediated
mitophagy. Life Sci. 315(121333)2023.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shetty S, Kumar R and Bharati S:
Mito-TEMPO, a mitochondria-targeted antioxidant, prevents
N-nitrosodiethylamine-induced hepatocarcinogenesis in mice. Free
Radic Biol Med. 136:76–86. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liu X, Wang X, Zhang J, Lam EK, Shin VY,
Cheng AS, Yu J, Chan FK, Sung JJ and Jin HC: Warburg effect
revisited: An epigenetic link between glycolysis and gastric
carcinogenesis. Oncogene. 29:442–450. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Cheng CT, Kuo CY, Ouyang C, Li CF, Chung
Y, Chan DC, Kung HJ and Ann DK: Metabolic Stress-induced
phosphorylation of KAP1 Ser473 blocks mitochondrial fusion in
breast cancer cells. Cancer Res. 76:5006–5018. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yi Y, Wu MY, Chen KT, Chen AH, Li LQ,
Xiong Q, Wang XR, Lei WB, Xiong GX and Fang SB: LDHA-mediated
glycolysis in stria vascularis endothelial cells regulates
macrophages function through CX3CL1-CX3CR1 pathway in noise-induced
oxidative stress. Cell Death Dis. 16(65)2025.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kooshan Z, Cárdenas-Piedra L, Clements J
and Batra J: Glycolysis, the sweet appetite of the tumor
microenvironment. Cancer Lett. 600(217156)2024.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang YJ, Chang LF, Xin X, Qiao YX, Qiao
WN, Ping JH, Xia J and Su J: Influenza A virus-induced glycolysis
facilitates virus replication by activating ROS/HIF-1α pathway.
Free Radic Biol Med. 250:910–924. 2024.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Qin Q, Li MY, Fan LL, Zeng X, Zheng DY,
Wang H, Jiang YT, Ma XR, Xing L, Wu LJ, et al: RVG engineered
extracellular vesicles-transmitted miR-137 improves autism by
modulating glucose metabolism and neuroinflammation. Mol
Psychiatry. 30:4072–4084. 2025.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yin H, Liu Y, Dong Q, Wang HY, Yan YJ,
Wang XQ, Wan XQ, Yuan GQ and Pan YW: The mechanism of extracellular
Cyp B promotes glioblastoma adaptation to glutamine deprivation
microenvironment. Cancer Lett. 597(216862)2024.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Rong J, Han CX, Huang Y, Wang YQ, Qiu Q,
Wang M, Wang SS, Wang R, Yang JQ, Li X, et al: Inhibition of
xanthine oxidase alleviated pancreatic necrosis via HIF-1
α-regulated LDHA and NLRP3 signaling pathway in acute pancreatitis.
Acta Pharm Sin B. 14:3591–3604. 2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Chelakkot C, Chelakkot VS, Shin Y and Song
K: Modulating glycolysis to improve cancer therapy. Int J Mol Sci.
24(2606)2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
An S, Yao Y, Hu HB, Wu JJ, Li JX, Li LL,
Wu J, Sun MM, Deng ZY, Zhang YY, et al: PDHA1
hyperacetylation-mediated lactate overproduction promotes
sepsis-induced acute kidney injury via Fis1 lactylation. Cell Death
Dis. 14(457)2023.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Rabinowitz JD and Enerbäck S: Lactate: The
ugly duckling of energy metabolism. Nat Metab. 2:566–571.
2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Liu J, Zhang C, Zhang TL, Chang CY, Wang
JM, Bazile L, Zhang LJ, Haffty BG, Hu WW and Feng ZH: Metabolic
enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to
promote cancer. Nat Metab. 4:1830–1846. 2022.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Rabbani N, Xue M and Thornalley PJ:
Hexokinase-2-linked glycolytic overload and unscheduled
Glycolysis-driver of insulin resistance and development of vascular
complications of diabetes. Int J Mol Sci. 23(2165)2022.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Qi W, Keenan HA, Li Q, Ishikado A, Kannt
A, Sadowski T, Yorek MA, Wu I, Lockhart S, Coppey LJ, et al:
Pyruvate kinase M2 activation may protect against the progression
of diabetic glomerular pathology and mitochondrial dysfunction. Nat
Med. 23:753–762. 2017.PubMed/NCBI View Article : Google Scholar
|
